Q&A: Treating Patients With Retinitis Pigmentosa With the Argus II


Gislin Dagnelie, MS, Associate Director, Lions Vision Research & Rehabilitation Center and James Tahara Handa, MD, Robert Bond Welch Professor of Ophthalmology, at Johns Hopkins Medicine, discuss the potential of the Argus II device to restore some vision to patients with retinitis pigmentosa.  The questions asked are below:

  1. What is Retinitis Pigmentosa (RP)

  2. How does the Argus II device correct the vision issues?

  3. What is involved in the surgical procedure

  4. How long does it take for vision to be restored after surgery?

  5. Do patients continue to learn how to use the device the more they use it?

  6. Who is eligible for this procedure? 

  7. What would you consider a successful outcome for a patient with the Argus II?

  8. Why is this device so important to patients and doctors?



Gislin Dagnelie

Gislin Dagnelie, MS

Associate Director, Lions Vision Research and Rehabilitation Center

James Handa

James Handa, MD

Robert Bond Welch Professor of Ophthalmology